FindTrial
Sign In

To check how reliable and valid the Kannada version of Michigan Neuropathy Screening Instrument is in diabetic neuropathy patients in comparison to the English version of the scale

Reliability and validity of Kannada version of Michigan Neuropathy Screening Instrument in diabetic Neuropathy patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078090
Enrollment
115
Registered
2024-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants who know Kannada and English, have age between 18 to 75 years and have a history of diabetes mellitus diagnosed by a physician and confirmed by either HbA1c greater than or equal to 6.5% or uses hypoglycemic agents

Exclusion criteria

Exclusion criteria: Participants with potential causes of neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiencies, autoimmune diseases, uremia, hypothyroidism, prolonged phenytoin use, consumption of immunosuppressive drugs and ethanol, presence of other neurological disorders affecting the sensory and motor systems such as stroke or gestational diabetes or chronic renal failure

Design outcomes

Primary

MeasureTime frame
Kannada version of Michigan Neuropathy Screening Instrument (MNSI)Timepoint: Immediate baseline—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr V Prem

Manipal Academy of Higher Education

prem.v@manipal.edu9886647732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026